Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Atorvastatin Calcium I.P. 10mg + Clopidogrel I.P. 75mg Tablets
Therapeutic Category
Cardiology, Cardiovascular
Dosage Form
Capsule
Packaging Type
Alu Alu
Packaging
10*10
Price
₹134/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Atorable C Tablet is a fixed-dose combination of Atorvastatin, a potent statin, and Clopidogrel, an antiplatelet agent, designed to provide dual protection for cardiovascular health. Atorvastatin works by inhibiting HMG-CoA reductase, the enzyme responsible for cholesterol synthesis, thereby lowering LDL cholesterol, total cholesterol, and triglycerides while modestly increasing HDL cholesterol. This helps prevent plaque buildup in arteries and slows the progression of atherosclerosis. Clopidogrel is a platelet aggregation inhibitor that works by irreversibly blocking the P2Y12 ADP receptor on platelets, reducing the risk of clot formation. The combination of lipid-lowering and antiplatelet action in Atorable C makes it an ideal choice for secondary prevention of cardiovascular events. It is commonly prescribed to patients with a history of myocardial infarction, ischemic stroke, peripheral artery disease, or following angioplasty/stent placement to reduce the risk of future heart attacks and strokes.
Common side effects include headache, dizziness, mild gastrointestinal disturbances (such as nausea or diarrhea), and muscle pain. Clopidogrel may increase the risk of bleeding or bruising. Rare but serious side effects include severe muscle injury (rhabdomyolysis), allergic reactions, and gastrointestinal bleeding. Patients should report any unusual bleeding, black/tarry stools, or unexplained muscle pain or weakness to their physician immediately.
Atorable C Tablet is indicated for the prevention of cardiovascular events such as heart attack and stroke in patients with established atherosclerotic cardiovascular disease or multiple risk factors. It is particularly used in patients requiring both cholesterol management and antiplatelet therapy after angioplasty or stent placement.
Atorable C should be taken only under strict medical supervision. It is contraindicated in patients with active liver disease, bleeding disorders, peptic ulcers, or known hypersensitivity to either component. It is not recommended during pregnancy or breastfeeding due to potential risks to the fetus or infant. Caution should be used in patients undergoing surgery or those taking other anticoagulant or antiplatelet medications, as this combination increases bleeding risk. Alcohol intake should be limited as it can enhance liver-related side effects of Atorvastatin. Regular lipid profile and liver function monitoring are recommended during therapy to ensure safety and effectiveness. Patients should avoid abrupt discontinuation unless advised by their physician, as it may increase the risk of cardiovascular events.
Store Atorable C Tablet in a cool, dry place below 30°C. Protect from moisture and direct sunlight. Keep the medication in its original packaging and out of reach of children. Do not use after the expiry date printed on the pack.
Composition : Atorvastatin 10mg + Aspirin 75mg + Clopidogrel 75mg Capsule
Composition : Atorvastatin (10mg) + Aspirin (75mg) Capsule
Composition : Atorvastatin Calcium I.P. 20mg + Clopidogrel I.P. 75mg + Aspirin I.P. 75mg Capsules
Composition : Atorvastatin Calcium I.P. 10mg + Clopidogrel I.P. 75mg Tablets
Composition : Atorvastatin Calcium I.P. 80mg Tablets
Composition : Atorvastatin Calcium I.P. 40mg Tablets
Composition : Atorvastatin Calcium I.P. 20mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg Tablets
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This cardiovascular combination has strong demand in the cardiology and chronic care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on heart disease prevention and long-term cardiovascular therapy portfolios.
Medical distributors and agencies can benefit from consistent demand for management and prevention of heart attack, stroke, atherosclerosis, high cholesterol, and blood clot formation. Atorvastatin helps reduce LDL cholesterol and supports arterial health Clopidogrel helps prevent platelet aggregation and clot formation Together, they provide strong dual cardiovascular protection and are widely used in post-cardiac event and high-risk patients, strengthening a reliable cardiology portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for this cardiovascular combination tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong chronic prescription demand, cardiologist preference, long-term therapy usage, stable repeat sales, reliable supply chain support, and good margins when partnering for this cardiac care product.
Medical distributors, stockists, and wholesalers interested in this combination tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, pricing, and distribution support.